Teva

ROMIDEPSIN

Manufacturer:

Teva

Romidepsin HCPCS:

J9318

HCPCS Code Descriptor:

Injection, romidepsin, non-lyophilized, 0.1 mg

Category:

J Code

Romidepsin NDCs:

00703-4004-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Romidepsin:

ROMIDEPSIN is an Oncology drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J9318 is aligned to the drug ROMIDEPSIN.

ACCESS PRICING AND MORE BY REGISTERING

J9318 Added Date:

October 1, 2021

J9318 Effective Date:

October 1, 2021

J9318 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Romidepsin billing and coding information.
Romidepsin patient assistance information can be found through KabiCare at the URL: https://kabicare.us/
ROMIDEPSIN prescribing information can be found at the link below:
Information regarding ROMIDEPSIN’s side effects can be found at MedlinePlus